Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
mtruong34's Profile
Displaying 401-450 of 505 result(s).
CYDY CytoDyn Inc
11/10/2020 11:11:58 AM
I'm predicting Regeneron's mab is n (7)
CYDY CytoDyn Inc
11/10/2020 9:02:16 AM
https://www.sciencedirect.com/scie (13)
CYDY CytoDyn Inc
11/10/2020 3:34:29 AM
https://www.kgw.com/mobile/article (8)
CYDY CytoDyn Inc
11/09/2020 7:11:17 PM
OK advanced warning, I'm not being (13)
CYDY CytoDyn Inc
11/08/2020 12:09:48 PM
Another drug has failed clinical tr (7)
CYDY CytoDyn Inc
11/06/2020 11:13:37 PM
Cytodyn added a new trial site toda (2)
CYDY CytoDyn Inc
11/06/2020 11:52:36 AM
I see no need to apologize. CYDY do
CYDY CytoDyn Inc
11/06/2020 11:24:25 AM
No Jake, it wasn't how the PR's wer (13)
CYDY CytoDyn Inc
11/05/2020 10:21:10 PM
Thanks Ohm for reviewing and clarif (1)
CYDY CytoDyn Inc
11/05/2020 8:53:10 PM
So it appears even very knowledgeab (4)
CYDY CytoDyn Inc
11/05/2020 8:14:18 PM
I think everyone here would agree t
CYDY CytoDyn Inc
11/05/2020 7:57:38 PM
https://www.fox4news.com/news/new- (3)
CYDY CytoDyn Inc
11/05/2020 7:33:56 PM
FDA has our CD-12 data and OWS has (2)
CYDY CytoDyn Inc
11/05/2020 7:30:01 PM
So the FDA DOES NOT have access to (3)
CYDY CytoDyn Inc
11/03/2020 11:51:19 AM
With only 19 employees, probably no (2)
CYDY CytoDyn Inc
11/02/2020 11:13:14 PM
Are they bold or foolish? We shall (1)
CYDY CytoDyn Inc
10/31/2020 6:36:31 PM
Agree, this article although appear (3)
CYDY CytoDyn Inc
10/31/2020 4:10:07 PM
Hopefully the 235 enrollment was th
CYDY CytoDyn Inc
10/31/2020 3:54:59 PM
235 current enrollment is only 5 si
CYDY CytoDyn Inc
10/30/2020 1:10:30 PM
Gotcha 'Stang. Appreciate your enth
CYDY CytoDyn Inc
10/30/2020 12:58:53 PM
"Must eliminate" Seriously. Please
CYDY CytoDyn Inc
10/30/2020 10:29:27 AM
https://finance.yahoo.com/news/bio (1)
CYDY CytoDyn Inc
10/30/2020 1:36:58 AM
https://youtu.be/Gu02_qHLlVg Let's (20)
CYDY CytoDyn Inc
10/29/2020 10:51:54 AM
https://www.sciencealert.com/how-c (2)
CYDY CytoDyn Inc
10/26/2020 11:38:57 AM
This will be interesting to follow. (2)
CYDY CytoDyn Inc
10/25/2020 2:38:14 PM
https://nypost.com/2020/10/25/ryqu (3)
CYDY CytoDyn Inc
10/24/2020 12:18:13 PM
Question: will the newly requested
CYDY CytoDyn Inc
10/23/2020 8:50:43 PM
https://video.foxbusiness.com/v/62 (4)
CYDY CytoDyn Inc
10/23/2020 8:29:09 PM
"I was under the assumption that th
CYDY CytoDyn Inc
10/23/2020 6:10:46 PM
But now knowing that the DSMC gave (2)
CYDY CytoDyn Inc
10/23/2020 5:48:52 PM
From today's Proactive video "the r (1)
CYDY CytoDyn Inc
10/23/2020 5:35:45 PM
I hear what you are saying Dr. Z bu (1)
CYDY CytoDyn Inc
10/23/2020 2:17:57 PM
Hey Enjay. Hmmm, I didn't know Mark (6)
CYDY CytoDyn Inc
10/23/2020 12:22:13 PM
Thanks for the reply Jeff. Yes, if
CYDY CytoDyn Inc
10/23/2020 12:15:16 PM
https://www.marketwatch.com/story/ (2)
CYDY CytoDyn Inc
10/23/2020 12:00:45 PM
I think the fact that Gilead's sp n (2)
CYDY CytoDyn Inc
10/23/2020 10:42:09 AM
Thanks Jeff! Very insightful and I (1)
CYDY CytoDyn Inc
10/22/2020 9:30:29 PM
This is how I think the recent full (2)
CYDY CytoDyn Inc
10/20/2020 8:37:26 AM
Cytodyn crew can't be that stupid t (2)
CYDY CytoDyn Inc
10/19/2020 8:06:06 PM
https://clinicaltrials.gov/ct2/his (1)
CYDY CytoDyn Inc
10/19/2020 6:05:27 PM
So I think adding a new site as rec (1)
CYDY CytoDyn Inc
10/19/2020 6:03:52 PM
Clinicaltrials.gov site updated Oct (1)
CYDY CytoDyn Inc
10/16/2020 5:32:10 PM
Dr. BP provided insight from his ex (1)
CYDY CytoDyn Inc
10/10/2020 10:03:33 PM
From another message board, these a (5)
CYDY CytoDyn Inc
10/10/2020 8:56:36 AM
Thanks Ohm. Leronlimab is indeed th (3)
CYDY CytoDyn Inc
10/10/2020 12:37:51 AM
Brief mention of leronlimab & refer (2)
CYDY CytoDyn Inc
10/08/2020 11:12:45 AM
samantha Mottet @MottetSamantha · (3)
CYDY CytoDyn Inc
10/08/2020 10:40:16 AM
samantha Mottet @MottetSamantha Rep (15)
CYDY CytoDyn Inc
10/07/2020 2:26:43 PM
https://video.foxbusiness.com/v/61 (7)
CYDY CytoDyn Inc
10/07/2020 9:58:49 AM
From Lilly's PR: The combination th (6)
Go to page:
  • << First
  • < Previous
  • 8
  • 9
  • Next >

Recent Articles

  • Analysis of Economic Growth: The Role of Tariffs and Revenue
  • Mortgage Rates Tumble to 6.72%, Housing Market Faces Challenges
  • PyroGenesis Plans Financial Results Call for Q2 2025 Insights
  • EchoStar Collaborates with MDA Space for Innovative Satellite Network
  • Energy Efficient Motors Poised for Significant Market Growth
  • Yacht Club de Monaco Celebrates Historic Admiral’s Cup Win
  • Partnership of MDA Space and EchoStar: A New Era in Satellite Technology
  • AITANA's Sold-Out Tour Concludes, Shaping the Future of Pop
  • Ray Dalio's Departure: A New Era for Bridgewater Associates
  • U.S. Auto Sales Trends: Mild Growth Forecast for July
  • Calamos Autocallable Income ETF Announces Dividend and Growth Plans
  • Mallinckrodt and Endo's Strategic Merger for Global Reach
  • LT Pro 48 Pickleball: Elevating the Game with PPA Tour
  • Flagstar Bank Chooses Mphasis for Cutting-Edge Tech Upgrade
  • TXNM Energy's Q2 2025 Earnings Showcase Strong Growth
  • EchoStar Partners with MDA Space for Groundbreaking LEO System
  • Calamos Autocallable Income ETF Sees Impressive Distribution Milestone
  • TELUS Achieves Impressive Growth and Financial Resilience
  • EchoStar Partners with MDA Space for Innovative Satellite Constellation
  • Brookfield Business Partners Achieves Growth Amid Economic Changes
  • Innovative Approaches Transforming Real Estate Franchise Success
  • Atlas Energy Expands Executive Team with Key Leadership Addition
  • T. Rowe Price Unveils Impressive Financial Results for Q2
  • Enbridge's Impressive Q2 Performance and Strategic Growth Plans
  • Dr. Trisha Bailey: A Journey from Challenges to Triumph
  • XCMG's Commitment to Europe: Building a Sustainable Future
  • Eurozone Inflation Remains Stable: Key Insights for Investors
  • Medicenna Therapeutics Achieves Key Milestones in Q1 Fiscal 2026
  • NANO Nuclear's Milestone: Inclusion in Leading Uranium Index
  • BioXcel Advances Treatment for Agitation in Bipolar Disorders
  • V2X Secures Landmark $4.3 Billion Contract with Air Force
  • Apex Critical Metals Joins OTCQX: A Milestone for Growth
  • Bosch Accelerates Growth in Global HVAC Market Strategy
  • PyroGenesis to Discuss Financial Results on Upcoming Call
  • Descartes Systems Group Announces Q2 Fiscal Results Call Date
  • Talga Group Ltd. Joins OTCQX: A New Era for Investors
  • TELUS Partners with La Caisse to Enhance Wireless Infrastructure
  • ANI Pharmaceuticals Plans Q2 2025 Financial Results Call
  • ANI Pharmaceuticals Reveals Upcoming Financial Call for Investors
  • Tesla Faces Sales Declines Across Europe Amid Market Struggles
  • Understanding ProVen Growth and Income VCT's Voting Rights Today
  • ProVen VCT plc Reports Total Voting Rights for Stakeholders
  • Apple's Surge and Key Stocks to Watch in Premarket Trading
  • Perella Weinberg Expands Advisory Services and Financial Outlook
  • MicroStrategy Inc. Shows Positive Trading Signals and Gains
  • LyondellBasell Gains Momentum with Strategic Q2 2025 Earnings
  • Regeneron Showcases Growth and Development in Q2 2025
  • EchoStar Highlights Financial Achievements and Growth in 2025
  • Top Tech Innovations This Week: Exciting Press Releases
  • Huya Boosts E-Sports Engagement with Delta Force Champions
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site